Parkinson DiseaseNCT06518824
Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
A study testing DBS On and DBS Off in people with Parkinson Disease and Cognitive Impairment, run by University of British Columbia at 1 site in Canada.
Trial summary
Cognitive impairment is common in Parkinson's disease. A recent study demonstrated 40% of people with PD suffer from mild cognitive impairment and > 80% of patients develop dementia after a disease duration of 20 years. Cognitive impairment significantly impairs quality of life and has limited treatment options. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Parkinson Disease, Cognitive Impairment
- What is being tested?
- DBS On and DBS Off
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 27 participants
- Where
- 1 siteCanada
- Study dates
- 23 Jan 2025to Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Those with STN DBS devices
- Those with pre- and post-operative imaging
- Those that are at least 3 months post-operative
Who cannot join
- Those unable to complete the cognitive task (due to language barriers or dementia)
- Those with significant DBS complications
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site, 1 recruiting
- Recruiting
Leslie and Gordan Diamond Health Care Centre
Vancouver, British Columbia, V5Z 1M9
Stefan Lang, MD PhD FRCSC, 604-875-5540, stefan.lang@vch.ca
About this study
Cognitive impairment is common in Parkinson's disease. A recent study demonstrated 40% of people with PD suffer from mild cognitive impairment and > 80% of patients develop dementia after a disease duration of 20 years. Cognitive impairment significantly impairs quality of life and has limited treatment options. While the pathophysiology of cognitive symptoms in PD is multifactorial, one contributing factor is dysfunction in subthalamic-cortical loops.
The subthalamic nucleus (STN) receives input from distributed regions of the cortex, forming partially segregated parallel networks with sensorimotor regions, associative (cognitive) cortical regions, and limbic cortical regions. These subthalamic-cortical networks are thought to play a domain general role in inhibitory control, which is a fundamental mechanism underlying flexible behavior across motor, cognitive, and affective domains. Information processing in these subthalamic-cortical networks is expressed through oscillatory activity within distinct frequency bands. For example, communication between the STN and prefrontal regions involved in executive function is thought to occur through coherence in the theta (4-8 Hz) frequency band. As a result of these observations, stimulation of the STN at a theta frequency has been investigated as a method of modulating cognitive processes.
Theta stimulation of the STN has been shown to enhance coherence in subthalamic-cortical networks, facilitating information processing and modulating behavior. For example, a recent study demonstrated that theta stimulation of the STN improved working memory performance in PD subjects, while no effect was seen for other frequency bands. The authors performed a post-hoc analysis and found that the effect may be mediated by connectivity between the stimulated STN region and the right dorsolateral prefrontal cortex (DLPFC). While these studies have demonstrated proof of principle, they are limited by small sample sizes and post-hoc analyses assessing the relationship between stimulation location and outcomes. Further research is needed to directly test the hypothesis that theta stimulation of the STN can improve executive control in PD patients by modulating associative STN circuitry.
Read the detailed description
Objective: The objective of the proposed research is to test the ability of theta stimulation of the STN to modulate cognitive processing in PD patients by stimulating the ventral, putatively associative territory of the STN.
Hypothesis: The hypothesis is that theta stimulation of the ventral (putatively associative) STN will improve performance on cognitive tasks compared to a control condition in which stimulation is delivered to the dorsal (putatively sensorimotor) STN.
Methods: Power analysis - with previously reported moderate effect sizes (Cohen's d=0.57), the investigators anticipate the need to recruit 27 subjects for a within-subject design with a power of 0.8 and an alpha level of 0.05.
Subjects: Patients with deep brain stimulation systems will be recruited from the Vancouver General Hospital DBS clinic. Subjects will be included if they have STN DBS, pre- and post-operative imaging (to allow electrode reconstruction), and are at least three months post-operative. Subjects will be excluded if they are unable to complete the cognitive task (due to language barriers or dementia) or if they have significant DBS related complications.
Study design: This is a double blind, randomized, cross-over within-subject repeated measure design assessing the interaction between stimulation location and behavioural modification. Subjects will be blinded to stimulation condition, and the individual administering the working memory task will also be blinded, as a neutral third party will program the DBS settings for each condition.
Electrode reconstruction and stimulation location: For each subject, the electrode is reconstructed using the Lead-DBS pipeline. A pre-operative MRI and a post-operative CT are co-registered and non-linearly normalized into standard space, and electrodes are identified and reconstructed using the PaCER algorithm, with manual refinement in native space where required. Directional lead orientation is determined from the CT artifact.
The protocol specified an individualized, connectivity-guided selection of stimulation contacts, with a pre-specified fallback to simplified ventral and dorsal configurations in the event that differential activation of the associative and sensorimotor networks proved unachievable given the anatomical location of the electrode or the electrode model. Review of the electrode reconstructions of enrolled and upcoming subjects indicated that configurations satisfying the connectivity criteria did not exist for a sufficient proportion of subjects. The fallback was therefore invoked, and after the first two subjects all stimulation was delivered using standardized ventral and dorsal montages.
These montages are defined by contact position along the lead rather than by individualized connectivity modelling. The ventral (associative) condition uses the most distal ring contact of each lead as cathode against the implantable pulse generator case as anode (left lead 0-/C+; right lead 8-/C+). The dorsal (sensorimotor) condition uses the most proximal ring contact as cathode in the same monopolar configuration (left lead 3-/C+; right lead 11-/C+). Stimulation is bilateral in both conditions. Because contact numbering follows a consistent dorsoventral ordering along the implanted leads, this fixed scheme produces a maximally separated ventral-versus-dorsal contrast within every subject's lead, independent of individual anatomy, and avoids confounding stimulation location with subject-specific programming decisions.
The ventral and dorsal designations are therefore a priori geometric labels, not verified per-subject network assignments. What was actually stimulated in each subject is established post hoc. For each subject and each theta condition, the electric field is simulated using the exact delivered montage, amplitude and pulse width, and overlap of the stimulation volume with the associative and sensorimotor territories of the STN is quantified in standard space using the DISTAL atlas, expressed as absolute volume, as a proportion of total stimulation volume, and as electric-field-weighted overlap. Structural connectivity between the stimulation volume and cortical regions of interest is estimated from normative structural connectomes as the number of streamlines traversing the stimulation volume and terminating in the region of interest; functional connectivity is estimated from normative resting-state connectomes as the Pearson correlation between the stimulation volume and the region of interest.
Baseline cognitive assessment: Each subject will undergo a baseline cognitive screening examination (Montreal Cognitive Assessment, MOCA), and that will be used as a covariate in future analysis.
Theta DBS: Subjects will come into the clinic on their regular medication schedule. The time since their last medication will be obtained, along with the participants levodopa equivalent daily dose (LEDD) to be used as a covariate to help control for the known non-linear contribution of dopamine to working memory. They will undergo a computerized working memory task while being stimulated in each of four following conditions:
- OFF
- Target condition: Theta (6 Hz) stimulation of the ventral (associative) STN.
- Anatomical control condition: Theta (6 Hz) stimulation of the dorsal (sensorimotor) STN.
- Frequency control condition: The subject's own clinically optimized high-frequency program.
These conditions will be randomized within each subject by creating a random integer (1-4) with no repeats. In the two theta conditions, pulse width is held at 60 µs and amplitude is set to the subject's clinical amplitude, matched across the two conditions so that delivered charge is equivalent and only the stimulation site differs. The clinical condition uses the subject's own programmed contacts, amplitude, pulse width and frequency. After changing the stimulation setting, there is a wash-out/wash-in period of at least 10 minutes prior to commencement of the working memory task. The subject will be asked if there is any unwanted stimulation side-effect (for example paresthesia). If the subject has paraesthesia or otherwise complains about the stimulation, the amplitude will be reduced by 0.5mA. If stimulation is not possible, the patient will be excluded from the study. Immediately before the working memory task commences, subjects will undergo a brief motor examination, consisting of items from the Unified Parkinson's Disease Rating Scale III. At the end of the session, the subjects will be placed back on their clinically optimized program and will continue to take their medication according to their normal schedule.
Working Memory Task: A modified Sternberg task will be presented using a laptop computer.
Statistical analysis: The primary outcome will be working memory performance during each stimulation condition as assessed by a linear mixed effect model. The model will be specified as working memory performance ~ age + MoCA + stimulation condition + baseline cognition*stimulation condition + stimulation order + (1|subject). The hypothesis is that there will be a main effect of stimulation condition on working memory performance, with post-hoc one sample t-tests demonstrating an improvement in the theta associative STN condition relative to the other conditions. An interaction effect of baseline cognition with stimulation condition is also expected to be observed. Based on previous literature, it is hypothesized that subjects with lower baseline cognition will have more improvement during associative STN region stimulation.
A secondary analysis will relate working memory performance to what was actually stimulated in each subject. For each subject, the degree to which the ventral and dorsal montages achieved the intended anatomical dissociation is quantified as overlap of the modelled electric field with the associative and sensorimotor STN territories, and as connectivity between the stimulation volume and dorsolateral prefrontal, primary motor and supplementary motor cortex. These measures will be tested as moderators of the effect of stimulation condition on working memory performance. The hypothesis is that subjects in whom the ventral montage produced greater associative-territory engagement will show greater working memory improvement during ventral theta stimulation.
By including the stimulation order variable, the investigators will adjust for the possibility that subjects performance will decline over time (due to fatigue) irrespective of the stimulation condition. Supplementary analysis will assess for motor performance during each stimulation condition, with the hypothesis that high frequency stimulation will have a reduction in motor scores compared to low frequency stimulation. Post-hoc analysis will also be performed to assess the relationship between task performance and functional and structural connectivity between the STN and associative networks, assuming there is some variability in individual connectivity strengths.
- Conditions
- Parkinson Disease, Cognitive Impairment
- Being tested
- DBS On, DBS Off
- Keywords
- Theta Stimulation
- Medical subject headings
- Parkinson Disease, Cognitive Dysfunction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DBS OnDevice
The DBS device will be turned on while the patient undergoes the working memory task.
DBS OffDevice
The DBS device will be turned off while the patient undergoes the working memory task.
| Study group | Role | What they receive |
|---|---|---|
| Stimulation off | Sham comparator | The deep brain stimulation device will be turned off. Receives: Device: DBS Off |
| Theta stimulation of associative STN region | Experimental | The deep brain stimulation device will be set to a frequency of 6 Hz and will stimulate the associative STN region. If differential activation of the associative and sensorimotor STN networks is not feasible, ventral stimulation is employed. Receives: Device: DBS On |
| Theta stimulation of STN sensorimotor region | Active comparator | The deep brain stimulation device will be set to a frequency of 6 Hz and will stimulate the sensorimotor region, acting as an anatomical control. If differential activation of the associative and sensorimotor STN networks is not feasible, dorsal stimulation is employed. Receives: Device: DBS On |
| High frequency stimulation of associative STN region | Active comparator | The deep brain stimulation device will be set to a frequency of 135 Hz and will stimulate the associative STN region, acting as a frequency control. If differential activation of the associative and sensorimotor STN networks is not feasible, ventral VTA is employed. Receives: Device: DBS On |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in working memory performance between conditions
Working memory performance will be assessed through a modified Sternberg task. Subjects will undergo the task with and without stimulation. Measures the main effect of stimulation condition, with hypothesis that theta stimulation of associative STN will improve performance compared to no stimulation. Outcome measured through percent of correctly recalled sequences.
Measured: Immediately after task performance
Secondary outcomes (1)
Interaction effect between groups and stimulation condition
A secondary analysis will categorize subjects into two groups: 1) those where differential targeting of the associative and sensorimotor STN networks was achieved and 2) those where differential targeting of these networks was not possible using the imaging-based criteria previously mentioned. The linear mixed-effect model will be repeated with the addition of an interaction term between group and stimulation condition. The hypothesis is that there will be a significant interaction effect between group and stimulation condition. Specifically, the investigators expect to observe an increase in working memory performance during the theta (6 Hz) stimulation of the associative STN network condition, within the subject group where differential targeting of the associative and sensorimotor STN networks was achieved.
Measured: Immediately after task performance
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jul 2024
- Study start23 Jan 2025
- Primary completionOct 2026 (estimated)
- Study completionOct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- More trials run by University of British ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 27 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Stefan Lang, University of British Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06518824
- Sponsor's protocol ID
- thetaDBS
- Status last verified
- Sep 2026
- First submitted
- 10 Jul 2024
- Last updated
- 14 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
- ClinicalTrials.gov ID
- NCT06518824
- Acronym / sponsor ID
- thetaDBS
- Conditions
- Parkinson Disease, Cognitive Impairment
- Keywords
- Theta Stimulation
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 27 participants (estimated)
- Lead sponsor
- University of British ColumbiaUniversity, hospital or other
- Study start
- 23 Jan 2025 (actual)
- Primary completion
- Oct 2026 (estimated)
- Study completion
- Oct 2026 (estimated)
- First posted
- 24 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cognitive impairment is common in Parkinson's disease. A recent study demonstrated 40% of people with PD suffer from mild cognitive impairment and > 80% of patients develop dementia after a disease duration of 20 years. Cognitive impairment significantly impairs quality of life and has limited treatment options. While the pathophysiology of cognitive symptoms in PD is multifactorial, one contributing factor is dysfunction in subthalamic-cortical loops.
The subthalamic nucleus (STN) receives input from distributed regions of the cortex, forming partially segregated parallel networks with sensorimotor regions, associative (cognitive) cortical regions, and limbic cortical regions. These subthalamic-cortical networks are thought to play a domain general role in inhibitory control, which is a fundamental mechanism underlying flexible behavior across motor, cognitive, and affective domains. Information processing in these subthalamic-cortical networks is expressed through oscillatory activity within distinct frequency bands. For example, communication between the STN and prefrontal regions involved in executive function is thought to occur through coherence in the theta (4-8 Hz) frequency band. As a result of these observations, stimulation of the STN at a theta frequency has been investigated as a method of modulating cognitive processes.
Theta stimulation of the STN has been shown to enhance coherence in subthalamic-cortical networks, facilitating information processing and modulating behavior. For example, a recent study demonstrated that theta stimulation of the STN improved working memory performance in PD subjects, while no effect was seen for other frequency bands. The authors performed a post-hoc analysis and found that the effect may be mediated by connectivity between the stimulated STN region and the right dorsolateral prefrontal cortex (DLPFC). While these studies have demonstrated proof of principle, they are limited by small sample sizes and post-hoc analyses assessing the relationship between stimulation location and outcomes. Further research is needed to directly test the hypothesis that theta stimulation of the STN can improve executive control in PD patients by modulating associative STN circuitry.
Detailed description
Objective: The objective of the proposed research is to test the ability of theta stimulation of the STN to modulate cognitive processing in PD patients by stimulating the ventral, putatively associative territory of the STN.
Hypothesis: The hypothesis is that theta stimulation of the ventral (putatively associative) STN will improve performance on cognitive tasks compared to a control condition in which stimulation is delivered to the dorsal (putatively sensorimotor) STN.
Methods: Power analysis - with previously reported moderate effect sizes (Cohen's d=0.57), the investigators anticipate the need to recruit 27 subjects for a within-subject design with a power of 0.8 and an alpha level of 0.05.
Subjects: Patients with deep brain stimulation systems will be recruited from the Vancouver General Hospital DBS clinic. Subjects will be included if they have STN DBS, pre- and post-operative imaging (to allow electrode reconstruction), and are at least three months post-operative. Subjects will be excluded if they are unable to complete the cognitive task (due to language barriers or dementia) or if they have significant DBS related complications.
Study design: This is a double blind, randomized, cross-over within-subject repeated measure design assessing the interaction between stimulation location and behavioural modification. Subjects will be blinded to stimulation condition, and the individual administering the working memory task will also be blinded, as a neutral third party will program the DBS settings for each condition.
Electrode reconstruction and stimulation location: For each subject, the electrode is reconstructed using the Lead-DBS pipeline. A pre-operative MRI and a post-operative CT are co-registered and non-linearly normalized into standard space, and electrodes are identified and reconstructed using the PaCER algorithm, with manual refinement in native space where required. Directional lead orientation is determined from the CT artifact.
The protocol specified an individualized, connectivity-guided selection of stimulation contacts, with a pre-specified fallback to simplified ventral and dorsal configurations in the event that differential activation of the associative and sensorimotor networks proved unachievable given the anatomical location of the electrode or the electrode model. Review of the electrode reconstructions of enrolled and upcoming subjects indicated that configurations satisfying the connectivity criteria did not exist for a sufficient proportion of subjects. The fallback was therefore invoked, and after the first two subjects all stimulation was delivered using standardized ventral and dorsal montages.
These montages are defined by contact position along the lead rather than by individualized connectivity modelling. The ventral (associative) condition uses the most distal ring contact of each lead as cathode against the implantable pulse generator case as anode (left lead 0-/C+; right lead 8-/C+). The dorsal (sensorimotor) condition uses the most proximal ring contact as cathode in the same monopolar configuration (left lead 3-/C+; right lead 11-/C+). Stimulation is bilateral in both conditions. Because contact numbering follows a consistent dorsoventral ordering along the implanted leads, this fixed scheme produces a maximally separated ventral-versus-dorsal contrast within every subject's lead, independent of individual anatomy, and avoids confounding stimulation location with subject-specific programming decisions.
The ventral and dorsal designations are therefore a priori geometric labels, not verified per-subject network assignments. What was actually stimulated in each subject is established post hoc. For each subject and each theta condition, the electric field is simulated using the exact delivered montage, amplitude and pulse width, and overlap of the stimulation volume with the associative and sensorimotor territories of the STN is quantified in standard space using the DISTAL atlas, expressed as absolute volume, as a proportion of total stimulation volume, and as electric-field-weighted overlap. Structural connectivity between the stimulation volume and cortical regions of interest is estimated from normative structural connectomes as the number of streamlines traversing the stimulation volume and terminating in the region of interest; functional connectivity is estimated from normative resting-state connectomes as the Pearson correlation between the stimulation volume and the region of interest.
Baseline cognitive assessment: Each subject will undergo a baseline cognitive screening examination (Montreal Cognitive Assessment, MOCA), and that will be used as a covariate in future analysis.
Theta DBS: Subjects will come into the clinic on their regular medication schedule. The time since their last medication will be obtained, along with the participants levodopa equivalent daily dose (LEDD) to be used as a covariate to help control for the known non-linear contribution of dopamine to working memory. They will undergo a computerized working memory task while being stimulated in each of four following conditions:
- OFF
- Target condition: Theta (6 Hz) stimulation of the ventral (associative) STN.
- Anatomical control condition: Theta (6 Hz) stimulation of the dorsal (sensorimotor) STN.
- Frequency control condition: The subject's own clinically optimized high-frequency program.
These conditions will be randomized within each subject by creating a random integer (1-4) with no repeats. In the two theta conditions, pulse width is held at 60 µs and amplitude is set to the subject's clinical amplitude, matched across the two conditions so that delivered charge is equivalent and only the stimulation site differs. The clinical condition uses the subject's own programmed contacts, amplitude, pulse width and frequency. After changing the stimulation setting, there is a wash-out/wash-in period of at least 10 minutes prior to commencement of the working memory task. The subject will be asked if there is any unwanted stimulation side-effect (for example paresthesia). If the subject has paraesthesia or otherwise complains about the stimulation, the amplitude will be reduced by 0.5mA. If stimulation is not possible, the patient will be excluded from the study. Immediately before the working memory task commences, subjects will undergo a brief motor examination, consisting of items from the Unified Parkinson's Disease Rating Scale III. At the end of the session, the subjects will be placed back on their clinically optimized program and will continue to take their medication according to their normal schedule.
Working Memory Task: A modified Sternberg task will be presented using a laptop computer.
Statistical analysis: The primary outcome will be working memory performance during each stimulation condition as assessed by a linear mixed effect model. The model will be specified as working memory performance ~ age + MoCA + stimulation condition + baseline cognition*stimulation condition + stimulation order + (1|subject). The hypothesis is that there will be a main effect of stimulation condition on working memory performance, with post-hoc one sample t-tests demonstrating an improvement in the theta associative STN condition relative to the other conditions. An interaction effect of baseline cognition with stimulation condition is also expected to be observed. Based on previous literature, it is hypothesized that subjects with lower baseline cognition will have more improvement during associative STN region stimulation.
A secondary analysis will relate working memory performance to what was actually stimulated in each subject. For each subject, the degree to which the ventral and dorsal montages achieved the intended anatomical dissociation is quantified as overlap of the modelled electric field with the associative and sensorimotor STN territories, and as connectivity between the stimulation volume and dorsolateral prefrontal, primary motor and supplementary motor cortex. These measures will be tested as moderators of the effect of stimulation condition on working memory performance. The hypothesis is that subjects in whom the ventral montage produced greater associative-territory engagement will show greater working memory improvement during ventral theta stimulation.
By including the stimulation order variable, the investigators will adjust for the possibility that subjects performance will decline over time (due to fatigue) irrespective of the stimulation condition. Supplementary analysis will assess for motor performance during each stimulation condition, with the hypothesis that high frequency stimulation will have a reduction in motor scores compared to low frequency stimulation. Post-hoc analysis will also be performed to assess the relationship between task performance and functional and structural connectivity between the STN and associative networks, assuming there is some variability in individual connectivity strengths.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Stimulation off | Sham comparator | Device: DBS OffThe deep brain stimulation device will be turned off. |
| Theta stimulation of associative STN region | Experimental | Device: DBS OnThe deep brain stimulation device will be set to a frequency of 6 Hz and will stimulate the associative STN region. If differential activation of the associative and sensorimotor STN networks is not feasible, ventral stimulation is employed. |
| Theta stimulation of STN sensorimotor region | Active comparator | Device: DBS OnThe deep brain stimulation device will be set to a frequency of 6 Hz and will stimulate the sensorimotor region, acting as an anatomical control. If differential activation of the associative and sensorimotor STN networks is not feasible, dorsal stimulation is employed. |
| High frequency stimulation of associative STN region | Active comparator | Device: DBS OnThe deep brain stimulation device will be set to a frequency of 135 Hz and will stimulate the associative STN region, acting as a frequency control. If differential activation of the associative and sensorimotor STN networks is not feasible, ventral VTA is employed. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Those with STN DBS devices
- Those with pre- and post-operative imaging
- Those that are at least 3 months post-operative
Key exclusion criteria (2 listed)
- Those unable to complete the cognitive task (due to language barriers or dementia)
- Those with significant DBS complications
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DBS OnThe DBS device will be turned on while the patient undergoes the working memory task. | Device | High frequency stimulation of associative STN region, Theta stimulation of STN sensorimotor region, Theta stimulation of associative STN region |
| DBS OffThe DBS device will be turned off while the patient undergoes the working memory task. | Device | Stimulation off |
Primary outcome
Change in working memory performance between conditions
Time frame: Immediately after task performance
Working memory performance will be assessed through a modified Sternberg task. Subjects will undergo the task with and without stimulation. Measures the main effect of stimulation condition, with hypothesis that theta stimulation of associative STN will improve performance compared to no stimulation. Outcome measured through percent of correctly recalled sequences.
1 secondary outcome
Interaction effect between groups and stimulation condition
Time frame: Immediately after task performance
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing DBS On and DBS Off in people with Parkinson Disease and Cognitive Impairment, run by University of British Columbia at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Stefan Lang, MD PhD FRCSC (604-875-5540, stefan.lang@vch.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in working memory performance between conditions (time frame: Immediately after task performance). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026.